Govt Job: For Ph.D, M.Pharm, M.Sc as Research Associate at AIIMS

All-India Institute of Medical Sciences (AIIMS) was established as an institution of national importance by an Act of Parliament with the object of developing patterns of teaching in undergraduate and postgraduate medical education in all its branches so as to demonstrate a high standard of medical education in India; bringing together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity, and attaining self-sufficiency in postgraduate medical education. 

The institute has comprehensive facilities for teaching, research, and patient care. As provided in the Act, AIIMS conducts teaching programs in medical and para-medical courses both at undergraduate and postgraduate levels and awards its own degrees.

Post : Research Associate – I

Project Title: “A randomized, open-label, parallel-group study to evaluate the safety and efficacy of abrocitinib 100 mg and 200 mg tablets in participants aged 12 years and older with moderate to severe atopic dermatitis in India,” funded by Pfizer.

Project code : N2272
Duration of project : 2 years

Emoluments : As per ICMR guidelines
Place of work : Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi.

Qualifications
i.  Ph.D / MD / MS / MDS OR
ii. MVSc / M.Pharm/ ME / M.Tech having 3 years of research experience with at least one publication in SCI journal

Age Limit : 40 years

Note
1. Only shortlisted candidates will be called for an interview. No TA/DA will be provided.

2. Send your CV with supporting documents in a single PDF file by email at dermatology.aiims12@adarsh

3. Please mention “Application for Research Associate-I in the subject line of the email.

Last date of receiving applications: July 17, till 5 PM.

Related Posts

Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

New Delhi: The Delhi High Court has ordered the e-commerce platform Meesho to take down listings of allegedly counterfeit sunscreen products of Sun Pharmaceutical Industries Ltd., granting interim relief in…

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

GUWAHATI: Indian Institute of Technology Guwahati researchers have developed an optical sensing device that can instantly detect a variety of toxicants in water and other biological samples. Aligned with the Government…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations